Sign in
4

Changes in Ownership

PULSE BIOSCIENCES, INC. Filed Acc 0001437749-26-005144

Chief Commercial Officer sold 5,000 shares at $23.64 ($118,200)

  • Chief Commercial Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Danahy Kevin Patrick Chief Commercial Officer 2026-02-18 Option exercise 10b5-1 +5,000 $1.53 $7,650 48,298 D
Danahy Kevin Patrick Chief Commercial Officer 2026-02-18 Sale 10b5-1 −5,000 $23.64 $118,200 43,298 D
Derivatives
Danahy Kevin Patrick Chief Commercial Officer 2026-02-18 Option exercise · Stock Option (right to buy) 10b5-1 −5,000 300,000 D
Open-market sales · 5,000 sh · avg $23.64 · $118,200
Loading xslF345X05/rdgdoc.xml…